Genoscience Pharma, Lactips and Phytowelt GreenTechnologies take home the 9th EuropaBio Biotech SME Awards
The awards were presented during a dinner ceremony in Brussels hosted by MEP Dr. Paul Rübig were each of the finalists took part in a ‘pitching session’, going head to head across the three categories and presenting their innovations to the audience. The keynote speech was given by Deputy Director-General Wolfgang Burtscher, DG Research, Science and Innovation of the European Commission who emphasised biotech as a key enabling technology and SMEs in this field will continue to play a core role in delivering on the aspirations of Horizon Europe.
Healthcare Biotech Category: Genoscience Pharma (FR)
Genoscience Pharma is an innovative SME located in Marseille, France that is in product development phase with their therapy against cancer stem cells, which are considered to be responsible for treatment resistance and mutation. Genoscience’s drug candidate has the potential to reduce the frequency of relapse when combined with chemotherapy.
Industrial Biotech Category: Lactips (FR)
Lactips is specialised in the development of eco-friendly plastic raw material. One of the materials they manufacture is the only thermoplastic, sound and clean bio-based and biodegradable material worldwide to be water-soluble at room temperature and made of milk protein. These outstanding properties are brought by the industrial mastering of the transformation of milk protein into processable polymers. To help with its project investment and recruitment activities, Lactips received funding of EUR 1.5 million from the EU Horizon 2020 SME Instrument phase 2.
Agricultural Biotech Category: Phytowelt GreenTechnologies (DE)
Phytowelt Green Technologies is an SME focussing on plant-breeding projects that aim at enabling regional production of renewable resources. It is the first company able to produce a biotech raspberry fragrance in high quantity and quality without using energy inefficient petrochemical processes, which helps meet the big and unmet demand of the perfume, food and cosmetic markets for natural fragrances and flavours.
Healthcare Biotech Category
Medicortex Finland (FIN) is a very promising SME that is still not on the market neither but managed to raise a €1.1M funding from private investors. Medicortex is dedicated to improving the diagnosis, treatment and prevention of acute neurodegenerative conditions and is currently focusing on developing a diagnostic kit for the detection of traumatic brain injury.
CHAIN Biotechnology (UK) is a microbiome company focused on the development and commercialisation of microbial technology for the production and delivery of biotherapeutics to the gut. The UK-based company’s technology has the potential to be highly disruptive both in terms of cost but also efficacy for the treatment and prevention of chronic and debilitating gut related diseases. Preclinical tests with their lead product showed a reduction of inflammation implicated in bowel diseases.
Industrial Biotech Category
Kaffe Bueno (DK) is a coffee recycling company founded by Colombian natives. The company combines used coffee grounds with biotechnology to create healthy ingredients to be used in pharmaceutical applications. They will open next year Scandinavia’s first coffee biorefinery where they will process coffee waste from Copenhagen and extract its oil and other bioactive compounds.
Agricultural Biotech Category
Alkol Biotech (UK) started three years ago and aims at developing new plant varieties able to grow in colder and drier climates offering better resistance to pests and diseases and higher productivities in order to meet the needs of the bio-based markets. They signed this year a letter of intent for the sourcing of up to 500 thousand tonnes of non-woody lignocellulosic biomass to what would be Europe’s largest biorefinery.